Affinity Biosciences

Affinity Biosciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

Affinity Biosciences is a private, revenue-generating reagent supplier based in Cincinnati, USA, with a strong reputation in the research tools market. The company has differentiated itself by building a world-leading library of over 2,300 phospho-specific antibodies and offers a range of products including primary/secondary antibodies, peptides, and customization services. It serves the global life science research community, as evidenced by over 36,500 published references, and has been recognized as a 'Supplier to Watch' in Europe. Its business model is centered on providing high-specificity, stable reagents to accelerate basic and translational research.

Antibodies

Technology Platform

Specialized platform for developing high-specificity antibodies, particularly phosphorylated antibodies, featuring the AFfirm™ monoclonal antibody system for stability and a professional antibody customization service.

Funding History

1
Total raised:$3M
Seed$3M

Opportunities

The growing focus on reproducible research and phosphoproteomics drives demand for high-quality, validated phospho-specific antibodies.
Expansion into new geographic markets and leveraging its customization service to build deep partnerships with biotech and pharma clients present significant growth avenues.

Risk Factors

Intense competition from large, global reagent suppliers and potential technological disruption from alternative binding molecules pose significant market risks.
The company's reputation is highly vulnerable to any quality control failures, which could erode trust built on its citation record.

Competitive Landscape

Affinity operates in the highly competitive life science research tools market, competing directly with giants like Cell Signaling Technology, Abcam, and Thermo Fisher Scientific, as well as numerous smaller specialists. Its differentiation is its deep focus on phosphorylated antibodies and claimed superiority in batch-to-batch consistency.